Table 4.
Item | Treatments1) | SEM | p-value | ||||
---|---|---|---|---|---|---|---|
| |||||||
NC | PC | EO100 | EO200 | EO400 | |||
Pre-starter II (25 days of experimentation) | |||||||
ALB (g/dL) | 1.87 | 1.81 | 1.74 | 1.84 | 1.80 | 0.055 | 0.718 |
ALT (U/L) | 67.86 | 59.59 | 62.87 | 53.72 | 64.42 | 3.729 | 0.202 |
AP (U/L) | 276.40 | 276.04 | 302.48 | 282.89 | 267.12 | 7.660 | 0.630 |
GLU (mg/dL) | 109.63 | 120.27 | 112.15 | 116.97 | 113.94 | 3.366 | 0.820 |
TP (g/dL) | 3.96B | 4.76A | 4.88A | 4.97A | 4.77A | 0.186 | 0.004 |
URE (mg/dL) | 10.98 | 8.91 | 9.47 | 10.60 | 9.89 | 0.384 | 0.241 |
ER (106/mm3) | 5.97 | 5.96 | 6.04 | 6.25 | 5.92 | 0.060 | 0.419 |
HG (g/dL) | 10.03 | 10.05 | 9.91 | 10.51 | 10.37 | 0.117 | 0.314 |
HT (%) | 30.59 | 31.44 | 30.56 | 32.41 | 32.00 | 0.283 | 0.105 |
MCV (fL) | 51.29b | 53.01ab | 50.70b | 51.97ab | 54.19a | 0.345 | 0.007 |
MCH (pg) | 19.58 | 18.98 | 19.58 | 20.26 | 19.18 | 0.234 | 0.393 |
MCHC (g/dL) | 32.78 | 31.93 | 32.42 | 32.42 | 32.39 | 0.210 | 0.776 |
PP (g/dL) | 5.05b | 5.43a | 5.30ab | 5.18ab | 5.23ab | 0.038 | 0.026 |
Platelets (103/mm3) | 716.18 | 644.25 | 643.06 | 695.53 | 662.67 | 17.909 | 0.652 |
Leucocytes (mm3) | 16,158 | 16,575 | 15,918 | 16,464 | 17,333 | - | 0.824 |
Band cells (%) | 0.00 | 1.63 | 0.00 | 0.00 | 0.00 | - | 0.160 |
Seg. neutrophils (%) | 43.59 | 33.50 | 41.88 | 44.47 | 42.72 | 1.384 | 0.097 |
Eosinophils (%) | 1.47 | 1.38 | 1.31 | 1.00 | 1.22 | - | 0.831 |
Basophils (%) | 0.18 | 4.44 | 0.13 | 0.12 | 0.00 | - | 0.303 |
Lymphocytes (%) | 51.76 | 56.56 | 53.81 | 52.00 | 53.94 | 1.415 | 0.843 |
Monocytes (%) | 3.00 | 2.50 | 2.88 | 2.41 | 2.11 | - | 0.658 |
Starter II (42 days of experimentation) | |||||||
ALB (g/dL) | 1.89 | 2.03 | 1.87 | 2.05 | 1.77 | 0.046 | 0.071 |
ALT (U/L) | 61.21 | 64.00 | 55.05 | 56.05 | 59.46 | 2.491 | 0.613 |
AP (U/L) | 374.28 | 361.14 | 381.32 | 389.84 | 365.81 | 9.478 | 0.880 |
GLU (mg/dL) | 106.79 | 105.63 | 108.96 | 109.26 | 104.57 | 2.699 | 0.803 |
TP (g/dL) | 5.26 | 5.24 | 5.36 | 5.08 | 4.93 | 0.114 | 0.431 |
URE (mg/dL) | 16.07 | 13.08 | 14.66 | 15.33 | 15.97 | 0.458 | 0.176 |
ER (106/mm3) | 6.36ab | 6.52ab | 6.71a | 6.59ab | 6.31b | 0.044 | 0.015 |
HG (g/dL) | 11.10 | 11.45 | 11.39 | 11.58 | 11.18 | 0.075 | 0.284 |
HT (%) | 34.50 | 34.94 | 35.00 | 35.71 | 34.67 | 0.208 | 0.521 |
MCV (fL) | 54.24ab | 53.60ab | 52.27b | 54.30ab | 55.09a | 0.307 | 0.013 |
MCH (pg) | 20.47ab | 21.38ab | 21.84a | 21.36ab | 20.36b | 0.165 | 0.011 |
MCHC (g/dL) | 32.19 | 32.78 | 32.55 | 32.43 | 32.26 | 0.110 | 0.425 |
PP (g/dL) | 5.31 | 5.48 | 5.49 | 5.44 | 5.36 | 0.043 | 0.345 |
Platelets (103/mm3) | 570.50 | 519.65 | 565.41 | 546.36 | 527.67 | 12.007 | 0.574 |
Leucocytes (mm3) | 15,000 | 14,864 | 14,170 | 13,621 | 14,022 | - | 0.528 |
Band cells (%) | 0.00c | 0.24a | 0.06cb | 0.21ab | 0.22ab | - | 0.004 |
Seg. neutrophils (%) | 39.19 | 35.88 | 36.76 | 39.79 | 36.72 | 0.947 | 0.594 |
Eosinophils (%) | 1.25 | 1.41 | 1.41 | 1.79 | 0.78 | - | 0.149 |
Basophils (%) | 3.56 | 0.00 | 0.00 | 0.07 | 0.00 | - | 0.350 |
Lymphocytes (%) | 52.25 | 58.76 | 57.41 | 52.43 | 59.39 | 1.174 | 0.142 |
Monocytes (%) | 3.75 | 3.71 | 4.35 | 3.64 | 2.89 | - | 0.378 |
SEM, standard error of the mean; ALB, albumin; ALT, alanine aminotransferase; AP, alkaline phosphatase; GLU, glucose; TP, total protein; URE, urea; ER, erythrocytes; HG, hemoglobin; HT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PP, plasma protein; Seg. neutrophils, segmented neutrophils.
NC, negative control: basal diet; PC, positive control: NC+125 mg performance-enhancing antibiotic (enramycin 8%)/kg diet; EO100, NC+100 mg essential oil blend/kg diet; EO200, NC+200 mg essential oil blend/kg diet; EO400, NC+400 mg essential oil blend/kg diet.
Averages with different uppercase superscripts in the same row differ significantly by the Student-Newman-Keuls test (p<0.05).
Averages with different lowercase superscripts in the same row differ significantly by the Tukey-Kramer test (p<0.05).